Want to join the conversation?
In March 2016, seven putative class action complaints have been filed in the US District Court for the Eastern District of Pennsylvania by indirect purchasers against $MYL, Mylan Pharmaceuticals & other pharma manufacturers alleging conspiracies to fix, raise, maintain & stabilize the prices of some product. $MYL intends to deny liability on this.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.